The Company incorporates its proprietary RDX technology into catheter-based systems that deliver beta radiation to the site of a treated blockage in an artery in order to decrease the likelihood of restenosis. The application of beta radiation inside the artery at the site of a blockage has proven clinically effective in inhibiting cell proliferation, a cause of restenosis. Expanded Business Description Financial Summary Radiance Medical Systems, Inc. designs, develops, manufactures and markets catheters used to treat certain vascular diseases, which enable physicians to deliver therapeutic radial force, stents, drugs or contrast media to the treatment site.
Revenues reflect increasing competition.
Higher loss reflects higher expenditures for US clinical trials. All Rights Reserved. Privacy Policy - Terms of Service Company information Copyright Market Guide . Data and information is provided for informational purposes only, and is not intended for trading purposes.